APA

Kisker O., Becker C. M., Prox D., Fannon M., D'Amato R., Flynn E., Fogler W. E., Sim B. K., Allred E. N., Pirie-Shepherd S. R. & Folkman J. (20011204). Continuous administration of endostatin by intraperitoneally implanted osmotic pump improves the efficacy and potency of therapy in a mouse xenograft tumor model. : Cancer research.

Chicago

Kisker O, Becker C M, Prox D, Fannon M, D'Amato R, Flynn E, Fogler W E, Sim B K, Allred E N, Pirie-Shepherd S R and Folkman J. 20011204. Continuous administration of endostatin by intraperitoneally implanted osmotic pump improves the efficacy and potency of therapy in a mouse xenograft tumor model. : Cancer research.

Harvard

Kisker O., Becker C. M., Prox D., Fannon M., D'Amato R., Flynn E., Fogler W. E., Sim B. K., Allred E. N., Pirie-Shepherd S. R. and Folkman J. (20011204). Continuous administration of endostatin by intraperitoneally implanted osmotic pump improves the efficacy and potency of therapy in a mouse xenograft tumor model. : Cancer research.

MLA

Kisker O, Becker C M, Prox D, Fannon M, D'Amato R, Flynn E, Fogler W E, Sim B K, Allred E N, Pirie-Shepherd S R and Folkman J. Continuous administration of endostatin by intraperitoneally implanted osmotic pump improves the efficacy and potency of therapy in a mouse xenograft tumor model. : Cancer research. 20011204.